Clinical Study of CS-001 As a Treatment for Canities (Grey Hair)
NCT06745336 · Status: NOT_YET_RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 240
Last updated 2024-12-24
Summary
Clinical Study to Assess the Safety and Efficacy of CS-001 as a treatment for Canities (Grey Hair)
Conditions
- Canities
- Grey Hair
Interventions
- DRUG
-
CS-001
CS-001 Topical Treatment
- DRUG
-
Placebo Topical Solution
Placebo Topical Solution
Sponsors & Collaborators
-
Complex Science
collaborator UNKNOWN -
Applied Biology, Inc.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-06-15
- Primary Completion
- 2027-06-15
- Completion
- 2027-09-15
More Related Trials
-
Efficacy and Tolerability Study of Two Dose Regimens of CTP-543 in Adults With Alopecia Areata
NCT03811912 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Study of DA-002 and DA-005 As a Treatment for Hair Loss
NCT06501924 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Safety, Tolerability, and Pharmacokinetics of Bimatoprost in Men With Androgenetic Alopecia (AGA)
NCT02676310 ·Status: TERMINATED ·Phase: PHASE1
-
Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia
NCT01501617 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Study to Investigate the Effectiveness of a Topical Cosmetic Formulation DA-OTC-002
NCT06095739 ·Status: COMPLETED ·Phase: NA
-
Topical Cetirizine in Treatment of Localized Alopecia Areata
NCT05803070 ·Status: UNKNOWN
-
Effect of Minoxidil Solution Iontophoresis on Androgenic Alopecia
NCT07056933 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Treatment of Alopecia Using Follicular Stem Cells
NCT05210452 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss
NCT05910450 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Trial of Topical Cidofovir for the Prevention of Hair Growth
NCT00948506 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Tolerability Study of Two Dosing Regimens of CTP-543 in Adults With Alopecia Areata
NCT03941548 ·Status: COMPLETED ·Phase: PHASE2
-
Minoxidil 1% for Eyebrow Enhancement
NCT01924000 ·Status: COMPLETED ·Phase: PHASE4
-
An Exploratory Clinical Study to Assess Safety, Efficacy and In-Use Tolerability of Three Different Hair Growth Products in Patients With Mild to Moderate Androgenic Alopecia (Grade I to III)
NCT06556056 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Efficacy and Safety of CTP-543 in Adults With Moderate to Severe Alopecia Areata (THRIVE-AA1)
NCT04518995 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment Results for Patients With Central Centrifugal Cicatricial Alopecia (CCCA): a Multicenter Prospective Study
NCT04207931 ·Status: RECRUITING ·Phase: PHASE4
-
Study to Evaluate Safety and Efficacy of SYHX1901 Tablets in Severe Alopecia Areata Patients
NCT06562894 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Minoxidil Response Testing in Females With Female Pattern Hair Loss
NCT02206802 ·Status: COMPLETED
-
Efficacy and Safety of 3% Minoxidil Lotion for Chest Hair Enhancement
NCT02283645 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate the Durability of Response of CTP-543 in Adult Patients With Moderate to Severe Alopecia Areata
NCT04784533 ·Status: COMPLETED ·Phase: PHASE2
-
Autologous Stromal Vascular Fraction in Treatment of Male Androgenic Alopecia
NCT06326359 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Clascoterone Solution in Treatment of Male Pattern Hair Loss (SCALP2)
NCT05914805 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study to Evaluate Safety and Efficacy of CTP-543 in Adults With Alopecia Areata
NCT03898479 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia
NCT01325337 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Efficacy and Safety of Rosnilimab (ANB030) in Treatment of Subjects With Moderate-to-Severe Alopecia Areata
NCT05205070 ·Status: UNKNOWN ·Phase: PHASE2
-
Minoxidil 2% for Eyebrow Enhancement
NCT01672307 ·Status: COMPLETED ·Phase: PHASE4